Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome

Adam Evans, Michael T. McCurdy, Menachem Weiner, Bledi Zaku, Jonathan H. Chow

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Angiotensin II is a novel vasopressor recently approved for the treatment of vasodilatory shock. We describe a case in which Angiotensin II was used to treat post–cardiopulmonary bypass vasoplegic syndrome in a patient who was refractory to standard vasopressors and other rescue therapies. Despite requiring high-dose vasopressors, the patient was extubated within 24 hours and has met key quality metrics defined by The Society of Thoracic Surgeons.

Original languageEnglish
Pages (from-to)e5-e7
JournalAnnals of Thoracic Surgery
Volume108
Issue number1
DOIs
StatePublished - Jul 2019

Fingerprint

Dive into the research topics of 'Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome'. Together they form a unique fingerprint.

Cite this